Health Care & Life Sciences » Pharmaceuticals | Huadong Medicine Co. Ltd.

Huadong Medicine Co. Ltd. A | Income Statement

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
16,652
18,866
21,627
25,248
27,669
30,492
Cost of Goods Sold (COGS) incl. D&A
13,394
14,840
16,574
19,289
20,630
21,938
Gross Income
3,258
4,026
5,053
5,959
7,038
8,554
SG&A Expense
2,214
2,715
3,469
4,024
4,752
5,673
EBIT
1,040
1,310
1,584
1,974
2,285
2,880
Unusual Expense
-
16
5
6
5
2
Non Operating Income/Expense
27
27
24
37
67
44
Interest Expense
132
162
199
109
82
129
Pretax Income
935
1,166
1,412
1,869
2,310
2,854
Income Tax
195
230
268
347
436
477
Equity in Affiliates
7
7
8
13
14
19
Consolidated Net Income
748
943
1,152
1,535
1,888
2,395
Net Income
575
757
1,097
1,447
1,780
2,267
Net Income After Extraordinaries
575
757
1,097
1,447
1,780
2,267
Net Income Available to Common
575
757
1,097
1,447
1,780
2,267
EPS (Basic)
0.44
0.58
0.84
1.00
1.22
1.30
Basic Shares Outstanding
1,302
1,302
1,302
1,447
1,458
1,750
EPS (Diluted)
0.44
0.58
0.84
1.00
1.22
1.30
Diluted Shares Outstanding
1,302
1,302
1,302
1,447
1,458
1,750
EBITDA
1,161
1,448
1,748
2,187
2,562
3,204
Other Operating Expense
3
2
-
39
1
2
Non-Operating Interest Income
8
9
10
42
35
51
Minority Interest Expense
173
186
55
89
109
128

About Huadong Medicine Co.

View Profile
Address
No. 866 Moganshan Road
Hangzhou Zhejiang 310011
China
Employees -
Website http://www.eastchinapharm.com
Updated 07/08/2019
Huadong Medicine Co., Ltd. engages in the production and sale of antibiotics, proprietary Chinese medicine, chemical synthetic medicine, and genetic engineering drugs. It involves in wholesale, retail, and distribution of Chinese and western medicine, Chinese herbal medicine, medical apparatus and instruments. Its products include Chinese medicine, drug immune agents, endocrine drugs, gastrointestinal agents, active pharmaceutical ingredient, hepatitis B medicine, and antineoplastic agents.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.